Payden & Rygel’s Quest Diagnostics Inc Position
Does Payden & Rygel own Quest Diagnostics Inc (DGX)? Yes — 76.6K shares worth $15M (+1.16% of its 13F portfolio) as of Q1 2026, down from 93.4K shares the prior filed quarter.
Position Value
$15M
Q1 2026
Shares
76.6K
% of Portfolio
+1.16%
Quarters Held
4
currently held
Position History DGX
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Payden & Rygel’s full portfolio or all institutional holders of DGX.